Literature DB >> 2487403

Impaired interleukin-2 receptor expression on lymphocytes from patients with chronic active hepatitis type B.

D S Ahn, H C Jang, J K Ahn, C Y Yim, D G Kim.   

Abstract

To evaluate cell mediated immunopathogenic mechanisms in chronic hepatitis B virus (HBV) infection, we investigated the changes of T4/T8 ratios from the peripheral blood, the percentages of IL-2 receptor expression after stimulation of mitogens (Con A, PHA) and a specific antigen (Hepatitis type B surface antigen, HBs), and the proliferative response mediated by IL-2 receptors after rIL-2 stimulation on mixed mononuclear cell. These experiments were performed comparatively in 5 groups which consisted of serologically negative normal subjects, chronic HBV carriers, patients with chronic active hepatitis (CAH) type B, patients with acute hepatitis (AH) type B, and the antibody positive healthy subjects. There were significant decreases of T4/T8 ratios in chronic HBV carriers, in patients with CAH type B, and in patients with AH type B, compared with negative normal controls. There were no significant differences between patients with CAH type B and the HBs negative normal controls in the percentage of IL-2 receptor positive cells after in-vitro HBs-stimulation and the proliferative response assessed by the incorporation of 3H-thymidine, whereas in patients with AH type B there were significant increases in both. Thus, in addition to a relatively decreased T4/T8 ratio, the impairment of IL-2 receptor expression on the lymphocytes after HBs-stimulation caused a defective response of cellular proliferation, and this might be one of the leading immunopathogenic roles in chronic HBV infection.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2487403      PMCID: PMC4534971          DOI: 10.3904/kjim.1989.4.1.34

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  19 in total

Review 1.  A suggested mechanism for T lymphocyte activation: implications on the acquisition of functional reactivities.

Authors:  E L Larsson; A Coutinho; C Martinez
Journal:  Immunol Rev       Date:  1980       Impact factor: 12.988

2.  Antigen-dependent regulation of interleukin 2 receptor expression on cloned human cytotoxic T lymphocytes.

Authors:  D R Kaplan; V L Braciale; T J Braciale
Journal:  J Immunol       Date:  1984-10       Impact factor: 5.422

3.  A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. I. Production of anti-Tac monoclonal antibody and distribution of Tac (+) cells.

Authors:  T Uchiyama; S Broder; T A Waldmann
Journal:  J Immunol       Date:  1981-04       Impact factor: 5.422

4.  Ligand-activated T cell growth factor-induced proliferation: absorption of T cell growth factor by activated T cells.

Authors:  G D Bonnard; K Yasaka; D Jacobson
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

5.  Cell-mediated immunity to hepatitis B surface antigen in man.

Authors:  R G Hanson; J H Hoofnagle; G Y Minuk; R H Purcell; J L Gerin
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

6.  Lymphocyte cytotoxicity to autologous hepatocytes in HBsAg positive chronic liver disease.

Authors:  G Mieli-Vergani; D Vergani; B Portmann; Y White; I Murray-Lyon; J H Marigold; I Woolf; A L Eddleston; R Williams
Journal:  Gut       Date:  1982-12       Impact factor: 23.059

7.  Selective sensitization of peripheral blood T lymphocytes to hepatitis B core antigen in patients with chronic active hepatitis type B.

Authors:  C Ferrari; A Penna; P Sansoni; T Giuberti; T M Neri; F V Chisari; F Fiaccadori
Journal:  Clin Exp Immunol       Date:  1986-12       Impact factor: 4.330

8.  Activation of virus specific CTL clones: antigen-dependent regulation of interleukin 2 receptor expression.

Authors:  M E Andrew; A M Churilla; T R Malek; V L Braciale; T J Braciale
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

9.  Interleukin 2 receptors on an insulin-specific T cell line: dynamics of receptor expression.

Authors:  A B Reske-Kunz; D von Steldern; E Rüde; H Osawa; T Diamantstein
Journal:  J Immunol       Date:  1984-09       Impact factor: 5.422

10.  Transient expression of interleukin 2 receptors. Consequences for T cell growth.

Authors:  D A Cantrell; K A Smith
Journal:  J Exp Med       Date:  1983-12-01       Impact factor: 14.307

View more
  1 in total

1.  He Jie Tang in the treatment of chronic hepatitis B patients.

Authors:  Ze-Xiong Chen; Shi-Jun Zhang; Shao-Xian Lao; Hong-Tao Hu; Cui-Yi Zhang; Shi-He Guan; Yan-Li Gu
Journal:  World J Gastroenterol       Date:  2005-11-14       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.